TL;DR: Section 301 tariffs on Chinese-manufactured goods, which evolved through 2025–2026, directly affect the landed cost of tampons and femcare products imported from China. For brands sourcing from China, the tariff impact adds 7.5–25% to the factory price depending on HTS classification. This guide covers the actual cost impact, legal mitigation strategies, and when alternative sourcing geography makes sense.
The Tariff Reality for Femcare Brands Sourcing from China
The Section 301 tariffs imposed on Chinese goods beginning in 2018 and subsequently modified through multiple rounds of USTR review have created a permanent cost variable that femcare brands sourcing from China must account for. Unlike the initial shock of 2018–2019 when brands were caught unprepared, by 2026 tariffs are a known cost input that can be modeled and managed — but still require careful planning.
For tampons and related feminine hygiene products, the tariff landscape is:
HTS Code 5601.21.0090 (Tampons of cotton): Base US tariff rate: 2.2% Section 301 List 3 additional tariff: 7.5% Effective rate: approximately 9.7% on customs (FOB) value
HTS Code 9619.00.7400 (Sanitary towels/pads, tampons — other): Base rate: 2.2% Section 301: 7.5% Effective rate: approximately 9.7%
HTS Code 6212.10 (Period underwear/brassieres — classified under textile apparel): Base rate: 16.5% Section 301: 7.5–25% depending on specific classification Effective rate: 24–41.5% — significantly higher than tampon classification
The tariff impact on period underwear sourcing is particularly significant and is a primary driver of manufacturing geography decisions for brands entering that category.
The Cost Impact in Practice
Scenario: Organic cotton tampon, 18-count box, OEM from China
| Cost Component | Without Tariff | With 9.7% Tariff | Impact |
|---|---|---|---|
| Factory EXW cost (18-count box) | $3.91 | $3.91 | — |
| Ocean freight to US | $0.85 | $0.85 | — |
| Import duties (base 2.2% on FOB) | $0.09 | $0.09 | — |
| Section 301 tariff (7.5% on FOB) | $0.00 | $0.29 | +$0.29 |
| Customs broker | $0.25 | $0.25 | — |
| Total landed cost | $5.10 | $5.39 | +5.7% |
At a $10.99 subscription retail price, a $0.29 increase in landed cost reduces gross margin from approximately 54% to 51% — meaningful but manageable.
Scenario: Period underwear, factory cost $9.00, from China
| Cost Component | Without S301 | With 25% S301 | Impact |
|---|---|---|---|
| Factory EXW cost | $9.00 | $9.00 | — |
| Ocean freight | $1.20 | $1.20 | — |
| Base import duty (16.5% on FOB) | $1.49 | $1.49 | — |
| Section 301 tariff (25% on FOB) | $0.00 | $2.25 | +$2.25 |
| Total landed cost | $11.94 | $14.19 | +18.8% |
At $28.00 retail, this period underwear goes from 57% gross margin to 49% — a 8-point margin reduction that changes the unit economics of the business significantly.
Legal Tariff Mitigation Strategies
Strategy 1: Correct HTS Classification
The most valuable first step in tariff management is ensuring your products are classified under the correct HTS code. Misclassification (particularly for period underwear, which can straddle textile apparel and medical device classifications) can result in paying a higher tariff rate than legally required.
Recommendation: Engage a licensed US customs broker or trade attorney to review your HTS classification before your first import. A one-time classification review costs $300–$800 and can save thousands in improperly paid duties. The correct classification for organic cotton tampons as medical devices (HTS 9619) rather than textile articles (HTS 5601) may carry a different tariff treatment.
Strategy 2: First Sale Valuation
For transactions where a US importer buys from a Chinese trading company that in turn buys from the factory, US Customs allows the use of the “first sale” price (the factory price to the trading company) as the basis for duty calculation rather than the higher trading company price. This can reduce the dutiable value by 15–30% where a trading company margin is involved.
Applicable when: You buy from a Chinese trading company or sourcing agent at a marked-up price above factory cost.
Strategy 3: Section 321 De Minimis for DTC Brands
For DTC brands shipping directly from overseas to US consumers, shipments valued at under $800 per package enter the US duty-free under Section 321 de minimis rules. This provision:
- Applies to individual consumer shipments (not wholesale or retail distribution)
- Allows DTC brands to source from China and fulfill directly without paying tariffs on individual orders
- Is subject to ongoing legislative scrutiny (Congress has debated reducing the de minimis threshold)
Practical application: A DTC tampon brand that uses a Chinese fulfillment center shipping individual subscription boxes directly to US consumers can leverage Section 321. However, this model requires in-country Chinese fulfillment capability and creates longer delivery times than domestic fulfillment.
Strategy 4: PFAS-Free and Organic Documentation for Classification Review
Medical devices that are properly registered with the FDA may be eligible for duty treatment as medical devices (HTS Chapter 90) rather than textile goods (HTS Chapter 56/62). This classification shift can reduce the base tariff rate. Consult with a trade attorney regarding the applicability of medical device classification to your specific product.
Alternative Sourcing Geographies: When China Isn’t the Only Answer
For brands where tariff impact is severe (particularly period underwear), alternative manufacturing geographies deserve evaluation:
Vietnam
Vietnam has emerged as a significant alternative to China for textile and garment manufacturing, including period underwear. Vietnam does not face Section 301 tariffs.
Advantages:
- Lower base import duty rates in some product categories
- Strong garment manufacturing capability
- Growing technical textile production base
- Eligible for some preferential trade programs
Disadvantages:
- Fewer certified femcare-specific OEM manufacturers than China
- Longer development timelines for specialized products
- Less established quality management infrastructure for medical-grade materials
Best for: Period underwear (high-tariff category in China), promotional bags, non-medical textile femcare accessories.
Bangladesh
Bangladesh is the world’s second-largest garment exporter with extremely competitive labor costs.
Advantages:
- Very low labor costs — lowest period underwear production cost globally
- BGMEA factory social compliance framework
- Growing certification infrastructure (GOTS, BSCI)
- GSP+ trade preferences with EU eliminate import duties
Disadvantages:
- Less developed medical device manufacturing capability
- Regulatory compliance for FDA/CE more complex to navigate
- Infrastructure challenges can cause supply disruptions
Best for: Standard period underwear for cost-sensitive market tiers, promotional femcare products.
India
India has significant organic cotton farming and processing capability, making it relevant for organic tampon and pad sourcing.
Advantages:
- Strong organic cotton supply chain (GOTS-certified Indian mills are well-established)
- No Section 301 tariffs
- Growing femcare manufacturing investment
Disadvantages:
- Less developed tampon-specific manufacturing infrastructure than China
- Longer lead times in some cases
- Quality consistency can be more variable
Best for: GOTS organic cotton sourcing, pad production for organic brands.
Multi-Sourcing Strategy for Tariff Resilience
The most sophisticated femcare brands in 2026 are not mono-geography sourced. They use a tiered multi-sourcing model:
- China: Core tampon production (lower tariff impact at 9.7%), organic cotton sourcing, specialized manufacturing (anion products, applicator tampons)
- Vietnam/Bangladesh: Period underwear (avoid high China textile tariffs), standard pads
- India: Organic cotton raw material sourcing, potential GOTS-certified production
This model requires more supply chain management but provides both tariff optimization and supply chain resilience — the latter being valuable after the supply disruptions of 2020–2022 taught brands the cost of single-geography dependency.
FAQ
Q: Will tariffs on Chinese femcare products increase or decrease in 2026–2027?
A: Trade policy is inherently unpredictable. As of mid-2026, Section 301 tariffs on most Chinese goods (including femcare products) remain at the levels established in the 2018–2019 trade war with modifications from subsequent USTR reviews. Monitor USTR.gov for Section 301 review updates, and build tariff variability into your financial models rather than assuming current rates are permanent.
Q: Can I avoid Section 301 tariffs by routing shipments through a third country?
A: No. “Transshipment” — routing goods through a third country to avoid origin-based tariffs without substantial transformation of the goods — is illegal and actively investigated by US Customs. Penalties include back-duties, fines, and exclusion from future imports. Do not attempt this.
Q: How do I account for tariff uncertainty in my pricing model?
A: Build tariff variability into your cost model as a sensitivity analysis. Model your unit economics at current tariff rates, at rates 5% higher, and at rates 10% higher. If the business is profitable at current rates but marginal at 10% higher rates, develop a contingency plan (price increase trigger, alternative sourcing qualification) before you need it.
📩 Discuss tariff-optimized OEM sourcing strategy for your femcare brand → [Contact tamponmanufacturer.com | Get A Quote]